Gamelin Erick
Chief Development Officer · 5 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | ACRV | Acrivon Therapeutics, Inc. | Award | 38,584 | $0.00 | $0.00 | filing |
| 2026-05-14 | ACRV | Acrivon Therapeutics, Inc. | Tax withholding | 404 | $1.92 | $775.68 | filing |
| 2026-02-14 | ACRV | Acrivon Therapeutics, Inc. | Tax withholding | 471 | $1.63 | $767.73 | filing |
| 2025-11-14 | ACRV | Acrivon Therapeutics, Inc. | Tax withholding | 403 | $2.24 | $902.72 | filing |
| 2025-08-14 | ACRV | Acrivon Therapeutics, Inc. | Tax withholding | 403 | $1.39 | $560.17 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.